BMO Capital analyst Jim Birchenough, M.D. weighed in on Arena Pharma (NASDAQ: ARNA) after IMS Health released prescription data for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE